Crown Entertainment/Discover Entertainment (post retracted)
Pharmawire Article on FDA approval of Latisse (Allergan)

Cosmetic and Reconstructive Eyelash Transplant / FDA Approves Latisse

At the 25th Annual Meeting of the American Academy of Cosmetic Surgery in Phoenix AZ, I was given the opportunity to present an update to last year's lecture on Cosmetic and Reconstructive Eyelash Transplantation.  Updates on technique (including advanced techniques, like the paired-follicle implantation and 'puppetteering' technique for curl orientation) were discussed.  Also presented was a review of the pertinent clinical data that led to the FDA's recent approval of Allergan's eyelash growth drug, Latisse(tm), inclding many before-and-after photos.  For information regarding the content of the lecture, please email me at doctorb@baumanmedical.com.   

comments powered by Disqus